Physician profile
Sheree E Brown
NPI 1629085881
$677.91
in general payments reported to CMS, 2019-2025
15 companies · $162 in 2025
The $162 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $158 · 2021: $11.95 · 2022: $97.13 · 2023: $80.03 · 2024: $169 · 2025: $162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $411.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $410.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $133.10 | 2022-2025 | Bravos Afterloader System, Somatom Go.Top |
| Daiichi Sankyo INC. | $131.94 | 2023-2025 | Enhertu |
| Gilead Sciences, INC. | $101.80 | 2024 | Trodelvy |
| Angiodynamics, INC. | $62.16 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $41.07 | 2022-2023 | Enhertu |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.41 | 2019 | |
| Tactile Systems Technology INC | $28.55 | 2024 | Entre Plus, Flexitouch Plus |
| Elekta, INC. | $26.93 | 2019 | |
| Tesaro, INC. | $21.37 | 2019 | |
| Seagen INC. | $20.14 | 2022 | |
| Macrogenics, INC. | $19.21 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $17.89 | 2024 | Libtayo |
| Eisai INC. | $14.39 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.00 | 2023 | |
| Boston Scientific Corporation | $11.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheree Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.